Limin Group (002734.SZ) announced the performance forecast for the first three quarters of 2024, expecting a net income attributable to shareholders of the listed company...
According to the report from the Zhitoon Finance APP, Limin Group (002734.SZ) announced the performance forecast for the first three quarters of 2024, expecting a net income attributable to shareholders of the listed company to be 49 million yuan - 53 million yuan, a year-on-year growth of 122.76% - 140.95%.
During the reporting period, the company's management team resolutely implemented the strategic development plan and operational objectives formulated by the board of directors, focusing on the deep cultivation and expansion of core businesses. this is to drive dual-wheel development in both international and domestic markets. The company has taken a series of measures such as strengthening weaknesses, cultivating internal strength to reduce costs and increase efficiency, optimizing resource allocation to ensure the improvement of key product project efficiency, building a 'biological synthesis' technology platform to accelerate 'biological manufacturing', and implementing group operation to promote management efficiency upgrades. Through these initiatives, the company's operational capabilities and the profitability quality of its core business have significantly improved, and its external investment projects have also achieved good returns.
